Finland Pharmaceuticals & Healthcare Q1 2020
Growth in Finland’s pharmaceutical market is expected to slow over the coming years. Finland's fragmented politicallandscape will continue to act as a headwind to policy formation over the coming years, delaying much-needed healthcare reformsand creating an uncertain market for drugmakers and healthcare providers. Nonetheless, as with many of its Western Europeanpeers, an ageing population and high per capita spending will ensure the demand for innovative medicines remain high over thelong term.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook